Emmessar Biotech & Nutrition Ratios

Emmessar Biotech & Nutrition Ltd Ratios

The Emmessar Biotech & Nutrition Ltd Ratios page provides a complete fundamental analysis of Emmessar Biotech & Nutrition Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Emmessar Biotech & Nutrition Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

Emmessar Biotech & Nutrition Ltd (NSE: , BSE: 524768) is currently trading at ₹25.91, with a market capitalization of ₹129.45M. As a major player in the Health technology sector and Pharmaceuticals: other industry, Emmessar Biotech & Nutrition Ltd remains a key stock for fundamental analysis using Emmessar Biotech & Nutrition Ltd Ratios.

Emmessar Biotech & Nutrition Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The Emmessar Biotech & Nutrition Ltd P/E ratio currently stands at 48.02, making it one of the most tracked metrics in Emmessar Biotech & Nutrition Ltd Ratios.

Historically, the Emmessar Biotech & Nutrition Ltd P/E ratio has shown strong fluctuations:

• 2024: 48.02
• 2023: 19.81
• 2022: 24.59
• 2021: 28.90
• 2020: 5.07

The rising Emmessar Biotech & Nutrition Ltd P/E ratio indicates increasing investor confidence and premium valuation.

Price to Book Ratio (P/B)

The Emmessar Biotech & Nutrition Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 1.97.

Historical P/B trend:

• 2024: 1.97
• 2023: 2.01
• 2022: 1.86
• 2021: 2.23

Emmessar Biotech & Nutrition Ltd shows reasonable valuation compared to its asset base.

Price to Sales Ratio (P/S)

The Emmessar Biotech & Nutrition Ltd P/S ratio currently stands at 24.85, an important part of Emmessar Biotech & Nutrition Ltd Ratios for revenue valuation.

Historical P/S ratio:

• 2024: 24.85
• 2023: 26.74
• 2022: 12.16
• 2021: 37.65

A stable or declining Emmessar Biotech & Nutrition Ltd P/S ratio indicates cautious market sentiment.

Emmessar Biotech & Nutrition Ltd Price to Cash Flow Ratio (P/CF)

The Emmessar Biotech & Nutrition Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 18.82.

Historical Emmessar Biotech & Nutrition Ltd Price to Cash Flow Ratio:

• 2024: 18.82
• 2023: 15.49
• 2022: 19.46
• 2021: 5.70
• 2020: 12.41

The rising Emmessar Biotech & Nutrition Ltd Price to Cash Flow Ratio indicates premium valuation based on cash flow.

Emmessar Biotech & Nutrition Ltd Enterprise Value Ratios

Enterprise Value (EV)

The Emmessar Biotech & Nutrition Ltd EV currently stands at ₹83.01M, representing the total company valuation including debt.

Historical EV trend:

• 2024: 83.01M
• 2023: 87.66M
• 2022: 72.72M
• 2021: 91.47M

Emmessar Biotech & Nutrition Ltd enterprise value consolidation suggests stable valuation.

EV/EBITDA Ratio

The Emmessar Biotech & Nutrition Ltd EV/EBITDA ratio is currently 0, a key metric in Emmessar Biotech & Nutrition Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

• 2024: 0
• 2023: 0
• 2022: 0
• 2021: 0

Stable Emmessar Biotech & Nutrition Ltd EV/EBITDA indicates balanced valuation.

Emmessar Biotech & Nutrition Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The Emmessar Biotech & Nutrition Ltd D/E ratio is currently 0, reflecting leverage and financial stability.

Historical D/E:

• 2024: 0
• 2023: 0.01
• 2022: 0.01
• 2021: 0

Emmessar Biotech & Nutrition Ltd maintains a strong balance sheet with low debt levels.

Return on Equity (ROE %)

The Emmessar Biotech & Nutrition Ltd ROE currently stands at 4.19%, showing profitability and capital efficiency.

Historical ROE:

• 2024: 4.19
• 2023: 10.66
• 2022: 7.85
• 2021: 8.01

Declining ROE indicates pressure on profitability.

Emmessar Biotech & Nutrition Ltd Ratios Analysis Summary

The Emmessar Biotech & Nutrition Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Emmessar Biotech & Nutrition Ltd stock is undervalued, fairly valued, or overvalued.

Tracking Emmessar Biotech & Nutrition Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.